BioCentury
ARTICLE | Clinical News

CyclASol: Phase II started

February 22, 2016 8:00 AM UTC

Novaliq began a double-blind, placebo-controlled, U.S. Phase II trial to compare 2 dose levels of twice-daily topical CyclASol vs. open-label Restasis cyclosporine ophthalmic emulsion 0.05% in about ...